Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: HB5 aptamer-tagged graphene oxide for co-delivery of doxorubicin and silibinin, and highly effective combination therapy in breast cancer

Fig. 7

Cytotoxicity of Free Apt (A), cGO (B), free DOX (C), free Sili (D), cGO-DOX (E), cGO-Sili (F), Apt-cGO-DOX (G), Apt-cGO-Sili (H), and Apt-cGO-DOX-Sili (I) on the MCF-10A, SK-BR-3, and MCF-7 cells in 48 h. The values are provided as mean ± SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs MCF-7 cells. #p < 0.05 and ##p < 0.01 vs MCF-10A cells. cGO: carboxylated graphene oxide; Apt: aptamer; DOX: doxorubicin; Sili: silibinin

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us